SensoMatt is a Portugal-based startup that leverages Artificial Intelligence to develop a solution for predicting pressure ulcers. The company's sensor sheet, decision core, and mobile app interface work together to accurately forecast the unpredictable nature of Pressure Ulcers. SensoMatt's mission is to minimize the distress and costs associated with pressure ulcers, particularly for the elderly and those with paralysis. The startup aims to make its solution cost-effective and scalable for global use, irrespective of the financial capability of hospitals and clinics worldwide. SensoMatt received a €60.00K grant investment in February 2022, which underscores the interest and belief in the potential of its innovative approach. As a startup in the hardware industry, SensoMatt's focus on utilizing AI for healthcare presents promising opportunities for future growth and impact. The company's vision of deploying its solution in all hospitals and clinics worldwide indicates a strong commitment to addressing a critical healthcare need on a global scale.
No recent news or press coverage available for SensoMatt.